Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma.

Autor: Boukari F; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France., Dugourd PM; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France., Chassang M; Department of Radiology, University of Nice Sophia Antipolis, Nice, France., Mondot L; Department of Radiology, Pasteur Hospital, University of Nice Sophia Antipolis, Nice, France., Passeron T; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.; INSERM, U1065, Centre Méditerranéen de Médecine Moléculaire, Team 12, Nice, France., Lacour JP; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France., Montaudie H; Department of Dermatology, University of Nice Sophia Antipolis, Nice, France.
Jazyk: angličtina
Zdroj: Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2017 Mar; Vol. 30 (2), pp. 262-264. Date of Electronic Publication: 2017 Mar 06.
DOI: 10.1111/pcmr.12562
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje